151 related articles for article (PubMed ID: 17635756)
1. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification.
Johnson DW; Armstrong K; Campbell SB; Mudge DW; Hawley CM; Coombes JS; Prins JB; Isbel NM
Nephrology (Carlton); 2007 Aug; 12(4):391-8. PubMed ID: 17635756
[TBL] [Abstract][Full Text] [Related]
2. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease.
Kwan BC; Murtaugh MA; Beddhu S
Clin J Am Soc Nephrol; 2007 Sep; 2(5):992-8. PubMed ID: 17702712
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death.
Hakeem A; Bhatti S; Dillie KS; Cook JR; Samad Z; Roth-Cline MD; Chang SM
Circulation; 2008 Dec; 118(24):2540-9. PubMed ID: 19047585
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study.
Ninomiya T; Kiyohara Y; Kubo M; Yonemoto K; Tanizaki Y; Doi Y; Hirakata H; Iida M
Am J Kidney Dis; 2006 Sep; 48(3):383-91. PubMed ID: 16931211
[TBL] [Abstract][Full Text] [Related]
8. Uric acid: a surrogate of insulin resistance in older women.
Chen LK; Lin MH; Lai HY; Hwang SJ; Chiou ST
Maturitas; 2008 Jan; 59(1):55-61. PubMed ID: 18082342
[TBL] [Abstract][Full Text] [Related]
9. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey.
Yu M; Ryu DR; Kim SJ; Choi KB; Kang DH
Nephrol Dial Transplant; 2010 Feb; 25(2):469-77. PubMed ID: 19762608
[TBL] [Abstract][Full Text] [Related]
11. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function.
Isbel NM; Haluska B; Johnson DW; Beller E; Hawley C; Marwick TH
Am Heart J; 2006 Mar; 151(3):745-53. PubMed ID: 16504645
[TBL] [Abstract][Full Text] [Related]
12. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population.
Rashidi A; Ghanbarian A; Azizi F
Clin J Am Soc Nephrol; 2007 Sep; 2(5):976-83. PubMed ID: 17702729
[TBL] [Abstract][Full Text] [Related]
13. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
[TBL] [Abstract][Full Text] [Related]
14. Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD.
Ramkumar N; Murtaugh MA; Cheung AK; Beddhu S
Am J Kidney Dis; 2007 Mar; 49(3):356-64. PubMed ID: 17336696
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
[TBL] [Abstract][Full Text] [Related]
16. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease.
Garland JS; Holden RM; Groome PA; Lam M; Nolan RL; Morton AR; Pickett W
Am J Kidney Dis; 2008 Nov; 52(5):849-58. PubMed ID: 18562059
[TBL] [Abstract][Full Text] [Related]
18. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
Minutolo R; De Nicola L; Mazzaglia G; Postorino M; Cricelli C; Mantovani LG; Conte G; Cianciaruso B
Am J Kidney Dis; 2008 Sep; 52(3):444-53. PubMed ID: 18468747
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance.
Boulon C; Lafitte M; Richeboeuf V; Paviot B; Pradeau V; Coste P; Bonnet J; Couffinhal T
Am J Cardiol; 2006 Dec; 98(11):1429-34. PubMed ID: 17126644
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
Gatti A; Morini E; De Cosmo S; Maiani F; Mandosi E; Fallarino M; Morano S; Trischitta V
Obesity (Silver Spring); 2008 Apr; 16(4):899-901. PubMed ID: 18239564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
